Back
Brainstorm Cell Therapeutics Vs. Aprea Therapeutics Industry Stock Comparison
Sell
9
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.78
Seasonality Move:
11.28%
Sell
4
APRE
Aprea Therapeutics
Last Price:
4.06
Seasonality Move:
-16.02%
Sell
9
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.86. The Score for BCLI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
4
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy, Sell or Hold?
- The current Aprea Therapeutics [APRE] share price is $3.92. The Score for APRE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- APRE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
APRE Stock Price Chart
What is Aprea Therapeutics's stock price today?
-
The Aprea Therapeutics share price today is $3.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 30.33 | Sell |
| Chaikin Money Flow: | -9175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.72) | Sell |
| Bollinger Bands (100): | (2.9 - 5.72) | Sell |
APRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 57.86 | Buy |
| Chaikin Money Flow: | -12418 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.61 - 4.05) | Buy |
| Bollinger Bands (100): | (3.06 - 4.1) | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.94 | Sell |
| 20-day SMA: | 2.07 | Sell |
| 50-day SMA: | 3.23 | Sell |
| 200-day SMA: | 5.54 | Sell |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 2.23 | Sell |
| 50-day EMA: | 3.06 | Sell |
| 200-day EMA: | 6.33 | Sell |
APRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.03 | Sell |
| 20-day SMA: | 3.49 | Buy |
| 50-day SMA: | 3.29 | Buy |
| 200-day SMA: | 4.74 | Sell |
| 8-day EMA: | 3.96 | Sell |
| 20-day EMA: | 3.67 | Buy |
| 50-day EMA: | 3.49 | Buy |
| 200-day EMA: | 4.34 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Aprea Therapeutics Earnings Growth & APRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $1.77 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aprea Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||